Prelone Alternatives Compared
Prelone | Avonex | Kesimpta |
|
---|
Prelone (prednisolone) | Avonex (interferon beta-1a) | Kesimpta (ofatumumab) |
|
|||||||
---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Asthma - acute, Bronchopulmonary Dysplasia, Bullous Pemphigoid, Dermatitis, Immunosuppression, Inflammatory Conditions, Multiple Sclerosis, Nephrotic Syndrome, Optic Neuritis... View more |
Prescription only
Avonex is a type of interferon beta-1a that may be used to treat adults with multiple sclerosis (MS). It is administered intramuscularly once weekly into the upper thigh. Headache, flu-like... View more |
Prescription only
Prescribed for Multiple Sclerosis. Kesimpta may also be used for purposes not listed in this medication guide. |
||||||||
More about Prelone (prednisolone) | More about Avonex (interferon beta-1a) | More about Kesimpta (ofatumumab) | ||||||||
Ratings & Reviews | ||||||||||
Be the first to share your experience with this drug. |
Avonex has an average rating of 7.2 out of 10 from a total of 46 ratings on Drugs.com. 68% of reviewers reported a positive effect, while 22% reported a negative effect. |
Kesimpta has an average rating of 6.7 out of 10 from a total of 66 ratings on Drugs.com. 48% of reviewers reported a positive effect, while 20% reported a negative effect. |
||||||||
Drug Class | ||||||||||
Side Effects | ||||||||||
See also: Prelone side effects in more detail. |
See also: Avonex side effects in more detail. |
See also: Kesimpta side effects in more detail. |
||||||||
Generic Availability | ||||||||||
Lower cost generic approved |
N/A |
N/A |
||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Kesimpta prices |
||||||||
Dosage Forms Available | ||||||||||
N/A |
|
|
||||||||
Brand Names | ||||||||||
Other prednisolone brands include: Millipred, Millipred DP, Orapred ODT, PediaPred | Other interferon beta-1a brands include: Avonex Pen, Avonex Prefilled Syringe, Rebif, Rebif Rebidose | Other ofatumumab brands include: Arzerra | ||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||
4 hours |
3 hours |
1476 hours |
||||||||
CSA Schedule ** View glossary of terms | ||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | ||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||
Drug Interactions | ||||||||||
A total of 590 drugs are known to interact with Prelone:
|
A total of 334 drugs are known to interact with Avonex:
|
A total of 160 drugs are known to interact with Kesimpta:
|
||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
Disease Interactions | ||||||||||
|
||||||||||
First Approval Date | ||||||||||
February 04, 1986 |
May 17, 1996 |
N/A |
||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||
N/A |
N/A |
|||||||||
More Information | ||||||||||
Patient resources | ||||||||||
Professional Resources | ||||||||||
N/A |
||||||||||
Related Treatment Guide | ||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.